February 1, 2025 India's Biocon plans IPO for biosimilars business by March 2026 Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for ...
Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance affordable access to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback